Anders Hedlund

Amministratore Delegato presso PERPETUA MEDICAL AB

Finance

Consumer Services

Electronic Technology

Profilo

Anders Hedlund is the founder of Nolsterby Invest AB, established in 2021, where the title held is Chief Executive Officer.
The current job is Chief Executive Officer & Director at Perpetua Medical AB, starting in 2024.
Former job includes Equity Analyst at Redeye AB from 2017 to 2021.
Education includes a graduate degree from the University of Uppsala, conferred in 2010.

Posizioni attive di Anders Hedlund

Società	Posizione	Inizio
PERPETUA MEDICAL AB	Amministratore Delegato	01/05/2024
Nolsterby Invest AB Nolsterby Invest AB Investment ManagersFinance Nolsterby Invest invests in companies located in Sweden. The firm focuses on medtech, diagnostics, biotech, life science tools & supplies, and healthtech. It participates in growth stage capital requirements.	Amministratore Delegato	01/08/2021

Tutte le posizioni attive di Anders Hedlund

Precedenti posizioni note di Anders Hedlund

Società	Posizione	Fine
Redeye AB Redeye AB Investment ManagersFinance Provides investment research	Analyst-Equity	01/08/2021

Vedi nel dettaglio l'esperienza di Anders Hedlund

Formazione di Anders Hedlund

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Anders Hedlund

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	4
University of Uppsala University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Redeye AB Redeye AB Investment ManagersFinance Provides investment research	Finance
Perpetua Medical AB Perpetua Medical AB Electronic Equipment/InstrumentsElectronic Technology Manufactures pharmacological measurements systems	Electronic Technology
Nolsterby Invest AB Nolsterby Invest AB Investment ManagersFinance Nolsterby Invest invests in companies located in Sweden. The firm focuses on medtech, diagnostics, biotech, life science tools & supplies, and healthtech. It participates in growth stage capital requirements.	Finance